4.94
Schlusskurs vom Vortag:
$5.06
Offen:
$5.05
24-Stunden-Volumen:
3.77M
Relative Volume:
1.03
Marktkapitalisierung:
$1.19B
Einnahmen:
$386.15M
Nettoeinkommen (Verlust:
$-56.39M
KGV:
-21.48
EPS:
-0.23
Netto-Cashflow:
$-55.19M
1W Leistung:
-6.08%
1M Leistung:
-25.60%
6M Leistung:
+16.24%
1J Leistung:
-18.21%
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ARDX
Ardelyx Inc
|
4.94 | 1.22B | 386.15M | -56.39M | -55.19M | -0.23 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-03 | Fortgesetzt | Raymond James | Strong Buy |
2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
2025-03-04 | Eingeleitet | BTIG Research | Buy |
2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
2021-03-23 | Eingeleitet | Wedbush | Outperform |
2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-10-20 | Fortgesetzt | Citigroup | Buy |
2020-02-18 | Fortgesetzt | Jefferies | Buy |
2020-02-12 | Eingeleitet | Citigroup | Buy |
2020-02-10 | Eingeleitet | Cowen | Outperform |
2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
2018-08-24 | Eingeleitet | Jefferies | Buy |
2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
2017-11-29 | Bestätigt | Citigroup | Buy |
2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Will Ardelyx Inc. continue its uptrendMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Measuring Ardelyx Inc.’s beta against major indices2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Is Ardelyx Inc. stock attractive for ETFsJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Will Ardelyx Inc. stock go up soon2025 Sector Review & Safe Entry Zone Tips - newser.com
What to do if you’re stuck in Ardelyx Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Why Ardelyx Inc. (41X) stock signals breakout potentialMarket Risk Summary & Expert Verified Movement Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Ardelyx (NASDAQ:ARDX) - MarketBeat
Using Python tools to backtest Ardelyx Inc. strategies2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
What analysts say about Ardelyx Inc stockGlobal Market Influence & Free Discover Breakout Stocks Early - earlytimes.in
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Ardelyx (NASDAQ:ARDX) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Short interest data insights for Ardelyx Inc.Weekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Detecting price anomalies in Ardelyx Inc. with AI2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Can Ardelyx Inc. hit a new high this monthJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Real time scanner hits for Ardelyx Inc. explained2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on Ardelyx Inc. stockWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Volatility clustering patterns for Ardelyx Inc.Bear Alert & Fast Gain Swing Alerts - newser.com
Ardelyx Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Trend Following Techniques - earlytimes.in
Is Ardelyx Inc. forming a reversal patternTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com
Will Ardelyx Inc. rebound enough to break evenTake Profit & Risk Controlled Daily Trade Plans - newser.com
Ardelyx, Inc. Stock Hits Day Low of $5.49 Amid Price Pressure - Markets Mojo
Ardelyx Becomes Oversold (ARDX) - Nasdaq
What drives Ardelyx Inc 41X stock priceDay Trading Setups & Machine Learning Stock Picks, Daily - earlytimes.in
Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Ardelyx, Inc. Hits Day Low of $5.49 Amid Price Pressure - Markets Mojo
What drives JPMPRL stock priceEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
What drives Ardelyx Inc stock priceChart Pattern Recognition & Receive Monthly Expert Trading Blueprints - earlytimes.in
Ardelyx (ARDX) Is Down 10.8% After Raising 2025 Sales Guidance – What's Changed - simplywall.st
Ardelyx (ARDX) Gets a Buy from Raymond James - The Globe and Mail
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ardelyx Inc-Aktie (ARDX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Williams Laura A | Chief Patient Officer |
Aug 26 '25 |
Sale |
6.12 |
80,000 |
489,680 |
366,322 |
Kelliher Mike | Chief Business Officer |
Aug 21 '25 |
Sale |
5.93 |
5,417 |
32,132 |
276,741 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):